Seres Therapeutics
MCRB
$1.02
Share price
-0.97%
Change (1 day)
-81.39%
Change (1 year)
Categories
Market capitalization of Seres Therapeutics (MCRB)
Market cap: $0.15 Billion
As of May 2024 Seres Therapeutics has a market cap of $0.15 Billion. This makes Seres Therapeutics the world's 7154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Seres Therapeutics from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.15 B | -14.88% |
| 2023 | $0.18 B | -74.06% |
| 2022 | $0.69 B | -8.85% |
| 2021 | $0.76 B | -65.84% |
| 2020 | $2.24 B | 825.95% |
| 2019 | $0.24 B | 30.78% |
| 2018 | $0.18 B | -54.98% |
| 2017 | $0.41 B | 2.87% |
| 2016 | $0.39 B | -70.87% |
| 2015 | $1.37 B |
End of Day market cap according to different sources
On May 11th, 2024 the market cap of Seres Therapeutics was reported to be:
$0.15 Billion
$0.15 Billion
$0.15 Billion
$0.15 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | $1.38 B | 799.72% | 🇺🇸 USA |
 Agios Pharmaceuticals
AGIO | $1.87 B | 1,116.33% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 6,997.10% | 🇺🇸 USA |